ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,322Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 398

$2.56M Total Retail Price of All Prescriptions

Rank: 2 out of 398

596 Patients Receiving at Least One Drug in Part D
31% Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Oklahoma
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

12% of this provider’s 596 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 596 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$97 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

44 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
CLONAZEPAM 1,034 115 150 B 1 51
HYDROCODONE-ACETAMINOPHEN 992 365 139 S3 2 2
CITALOPRAM HBR 583 116 98 3 20
OMEPRAZOLE 569 189 81 4 4
LISINOPRIL 543 274 78 5 3
GABAPENTIN 521 153 82 6 11
RISPERIDONE 506 89 90 A 7 89
QUETIAPINE FUMARATE 497 39 79 A 8 76
TRAZODONE HCL 486 <11 80 9 37
ZOLPIDEM TARTRATE 472 88 77 10 19
ALPRAZOLAM 458 49 72 B 11 23
LEVOTHYROXINE SODIUM 436 208 55 12 1
FUROSEMIDE 410 227 69 13 7
SIMVASTATIN 406 229 55 14 6
BENZTROPINE MESYLATE 392 12 41 R 15 172
METFORMIN HCL 387 158 60 16 9
POTASSIUM CHLORIDE 362 162 59 17 10
OLANZAPINE 351 53 44 A 18 126
NAMENDA 331 210 31 19 29
INVEGA SUSTENNA 306 24 41 A 20 243
ESCITALOPRAM OXALATE 292 94 37 21 42
LAMOTRIGINE 285 20 41 22 134
TRAMADOL HCL 285 79 54 22 15
FLUOXETINE HCL 280 42 45 24 46
MIRTAZAPINE 274 <11 41 25 66
POLYETHYLENE GLYCOL 3350 256 120 41 26 69
ABILIFY 251 44 37 A 27 120
CYMBALTA 247 12 35 28 39
SERTRALINE HCL 247 51 36 28 26
VENLAFAXINE HCL ER 246 <11 48 30 97
AMLODIPINE BESYLATE 234 129 32 31 5
ATORVASTATIN CALCIUM 232 101 30 32 8
ROPINIROLE HCL 230 69 34 33 92
DIVALPROEX SODIUM ER 219 <11 37 34 174
SEROQUEL XR 204 <11 36 A 35 229
PROAIR HFA 202 31 45 36 41
CLOZAPINE 194 14 15 A 37 147
ATENOLOL 187 85 27 38 25
LATUDA 186 26 24 A 39 261
FENTANYL 182 59 28 S2 40 82
HYDROCHLOROTHIAZIDE 174 51 24 41 13
FENOFIBRATE* 172 21 16 42 100
DEXILANT 171 92 15 43 169
WARFARIN SODIUM 168 126 14 44 18
PAROXETINE HCL 167 19 18 45 58
DIVALPROEX SODIUM 161 32 15 46 129
RANITIDINE HCL 161 21 22 46 50
DONEPEZIL HCL 159 122 23 48 30
FAZACLO 159 <11 <11 A 48 250
METOPROLOL TARTRATE 158 46 24 50 12
DIAZEPAM 154 12 21 B 51 81
CLOPIDOGREL 153 90 22 52 16
MELOXICAM 152 40 24 53 24
NEXIUM 144 51 19 54 33
CARISOPRODOL 140 12 20 R 55 75
PHENYTOIN SODIUM EXTENDED 138 52 15 56 135
TIZANIDINE HCL 133 15 22 57 109
TOPIRAMATE 130 25 17 58 127
LANTUS 125 82 22 59 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 63 19 60 32
NAPROXEN 124 17 16 60 99
LEVETIRACETAM 123 15 16 62 116
TAMSULOSIN HCL 121 72 18 63 28
HYDROXYZINE PAMOATE 119 <11 20 R 64 224
LOVAZA 118 59 11 65 201
PANTOPRAZOLE SODIUM 117 28 19 66 36
ENALAPRIL MALEATE 115 31 11 67 80
BUPROPION HCL SR 115 <11 21 67 170
CIPROFLOXACIN HCL 115 62 76 67 61
OXYCODONE HCL 115 30 16 S2 67 68
OXYCODONE HCL-ACETAMINOPHEN 107 30 17 S2 71 85
PROPRANOLOL HCL 102 24 15 72 110
SUCRALFATE 97 51 14 73 125
LOSARTAN POTASSIUM 96 48 12 74 22
CLONIDINE HCL 95 32 25 75 44
IBUPROFEN 92 21 24 76 87
METOPROLOL SUCCINATE 92 32 13 76 17
SAPHRIS 89 0 11 A 78 326
AMITRIPTYLINE HCL 88 39 12 R 79 65
CELEBREX 86 <11 <11 80 72
OXCARBAZEPINE 84 <11 <11 81 290
PREDNISONE 84 43 24 81 43
CARVEDILOL 83 26 15 83 21
BUSPIRONE HCL 83 0 11 83 115
MEDROXYPROGESTERONE ACETATE 83 <11 <11 83 238
ZETIA 80 <11 <11 86 93
HALOPERIDOL 74 <11 <11 A 87 230
TRIHEXYPHENIDYL HCL 73 <11 <11 R 88 338
TRIAMCINOLONE ACETONIDE 73 45 26 88 138
LITHIUM CARBONATE 73 <11 <11 88 233
SPIRONOLACTONE 73 46 13 88 70
MONTELUKAST SODIUM 73 <11 <11 88 38
TEMAZEPAM 70 16 14 B 93 64
VENLAFAXINE HCL 68 <11 <11 94 190
FAMOTIDINE* 67 27 13 95 84
LORAZEPAM 66 <11 16 B 96 49
CRESTOR 63 21 11 97 34
JANUVIA 63 31 12 97 59
PRAVASTATIN SODIUM 62 24 11 99 14
CYCLOBENZAPRINE HCL 62 24 12 R 99 52
FLUTICASONE PROPIONATE 62 15 13 99 27
FANAPT 62 0 19 A 99 352
PREMARIN 60 31 11 R 103 88
CEPHALEXIN 59 29 46 104 137
GEMFIBROZIL 59 17 11 104 107
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 30 36 106 104
ZIPRASIDONE HCL 56 0 11 A 107 271
LYRICA 53 28 11 108 53
LACTULOSE 53 14 15 108 167
CARBAMAZEPINE XR 51 <11 <11 110 385
LEVOFLOXACIN 50 35 36 111 73
MEGESTROL ACETATE 50 37 15 R 111 142
HYDROXYZINE HCL 50 <11 <11 R 111 227
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 24, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.